Ilke Nalbantoglu

Dr. Ilke Nalbantoglu is an Associate Professor of Pathology at Yale School of Medicine, specializing in hepatic and gastrointestinal pathology. She holds an MD from Ege University School of Medicine and has appointments in the departments of Pathology, Gastrointestinal (GI) & Liver Pathology, and Surgical Pathology. Her research focuses on liver diseases, molecular diagnostics, and gastrointestinal pathology with notable contributions to Wilson disease screening and metabolic-associated steatohepatitis (MAS) clinical trial infrastructure. Dr. Nalbantoglu has published extensively on topics including gastric histopathology, hepatocellular carcinoma mechanisms, and cholangiopathies.

Education: M.D., Ege University School of Medicine.

Research Interests:

• Wilson Disease diagnosis via metallothionein immunohistochemistry
• Liver transplant histopathology in hepatitis C patients
• Apobec1 factor's role in hepatic steatosis progression
• Diagnostic algorithms for cholangiopathies
• Molecular underpinnings of hepatocellular cancer

Recent Work Trends: Her 2023-2025 publications emphasize diagnostic innovations in liver pathology, molecular mechanisms of hepatic diseases, and translational research for clinical applications. She collaborates with teams advancing MAS diagnostic standards and precision oncology approaches.

Awards: No specific awards listed in provided materials.

Labs/Teams: Active in Yale's Pathology Department research groups and collaborative networks including the Precision Medicine Tumor Board.